Tag Archives: cancer vaccines immunotherapy

ASCO Oncology Stocks: Recap and Scoreboard- AGIO, MDVN, SGEN Winners

High Profile Biotechnology Companies with ASCO Presence Investors and traders waited toward the end of the ASCO Annual Meeting week to buy their favorite stocks. The biotech sector overall was boosted after the close of the meeting after a brief sell-off on June 2 and 3. Most biopharmaceutical stocks peaked in late February so ASCO […]

Comments Off Continue Reading →

Rayno Life Science Portfolio: ILMN, PCYC, RGDX

Market Can’t Stay Down in Quiet Trading After a couple of lackluster trading days the market perked up as economic news continues positive with retail sales up for the  fourth consecutive month and many analysts believing Europe is coming out of recession. And the Icahn effect is back as Carl Icahn reveals his Apple (AAPL) […]

Comments Off Continue Reading →

Innovation Drives Market Gains in Biopharmaceuticals

This article was published in Genetic Engineering News in the section “Wall Street Biobeat” on April 1, 2011. Monoclonal antibody therapies remain the dominant technology with immunotherapy and stem cell therapies on the horizon. GEN | Articles: Innovations Continue to Drive Market Gains Emerging Technologies in Biomedicine-Continuing Series Published in Genetic Engineering News April 1 […]

Comments Off Continue Reading →

Amgen(AMGN) To Buy Biovex For Cancer Vaccine Technology

Biologics for Treatment of Cancer and Prevention of Infectious Disease Amgen(AMGN) and  Biovex said today that both Boards approved the sale of privately held Biovex for $425M with milestone payments as much as $525M. The Biovex lead product OncoVex, an oncolytic vaccine, is in a Phase III multinational study for metastatic melanoma. A second study […]

Comments Off Continue Reading →